NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-043-2008-0-GB-08 Anti-HIV Domain Antibodies and Methods of Making and Using Same GB EP 09700209.1 Issued
NCI E-043-2008-0-DE-06 Anti-HIV Domain Antibodies and Methods of Making and Using Same DE EP 09700209.1 Issued
NCI E-043-2008-0-FR-07 Anti-HIV Domain Antibodies and Methods of Making and Using Same FR EP 09700209.1 Issued
NIAID E-285-2002-0-US-13 LUTZOMYIA LONGIPALPIS POLYPEPTIDES AND METHODS OF USE US DIV 12/350,179 8628780 Issued PDF
NCI E-043-2008-0-PCT-02 Anti-HIV Domain Antibodies and Methods of Making and Using Same PCT PCT PCT/US2009/030351 Expired
NIAAA E-092-2006-0-FR-12 Ketone bodies and ketone body esters as blood lipid lowering agents FR EP 09701051.6 Issued
NIAAA E-092-2006-0-DE-09 Ketone bodies and ketone body esters as blood lipid lowering agents DE EP 09701051.6 Issued
NIAAA E-092-2006-0-NL-14 Ketone bodies and ketone body esters as blood lipid lowering agents NL EP 09701051.6 Issued
NIAAA E-092-2006-0-GB-13 Ketone bodies and ketone body esters as blood lipid lowering agents GB EP 09701051.6 Issued
NIAAA E-092-2006-0-TR-16 Ketone bodies and ketone body esters as blood lipid lowering agents TR EP 09701051.6 Issued
NIAAA E-092-2006-0-ES-11 Ketone bodies and ketone body esters as blood lipid lowering agents ES EP 09701051.6 Issued
NIAAA E-092-2006-0-SE-15 Ketone bodies and ketone body esters as blood lipid lowering agents SE EP 09701051.6 Issued
NIAAA E-092-2006-0-EP-05 Ketone bodies and ketone body esters as blood lipid lowering agents EP National Stage 09701051.6 Issued
NIAAA E-092-2006-0-DK-10 Ketone bodies and ketone body esters as blood lipid lowering agents DK EP 09701051.6 Issued
NIAAA E-092-2006-0-BE-08 Ketone bodies and ketone body esters as blood lipid lowering agents BE EP 09701051.6 Issued
NIAAA E-092-2006-0-IN-06 Ketone bodies and ketone body esters as blood lipid lowering agents IN National Stage 1655/MUMNP/2010 Issued
NIAAA E-092-2006-0-US-07 Ketone Bodies And Ketone Body Esters As Blood Lipid Lowering Agents US National Stage 12/811,648 9211275 Issued PDF
NIAAA E-092-2006-0-AU-03 Ketone bodies and ketone body esters as blood lipid lowering agents AU National Stage 2009204370 Issued
NIAAA E-092-2006-0-PCT-02 Ketone bodies and ketone body esters as blood lipid lowering agents PCT PCT PCT/US2009/030095 Expired
NIAAA E-092-2006-0-CN-04 Ketone bodies and ketone body esters as blood lipid lowering agents CN National Stage 200980104958.2 Abandoned
NIA E-016-2009-0-US-01 Design And Generation Of Membrane-targeting And Epitope-tagging Module For Subcloning And Expression Ofmammalian Membrane Proteins US 61/142,531 Abandoned
NCI E-287-2009-1-US-01 Antiproliferative Factors And Methods Of Use US 61/142,407 Abandoned
NHLBI E-209-2007-0-PCT-02 Active 0.035" Guidewire With Two Separate Channels PCT PCT PCT/US2008/088655 Expired
NIAID E-204-2008-0-US-01 LJL143 Sand Fly Salivary Protein, A Novel Factor Xa Inhibitor US 61/142,107 Abandoned
NIAID E-205-2008-0-US-01 Sand Fly Salivary Proteins (LJM04, LJM11, LJM26, LJL143, And LJMI9) Which Have Anti-complement Activity And May Be Used To Treat Complement-related Diseases, And Also As Potential Leishimania Vaccine Candidates US 61/142,098 Abandoned
NCI E-064-2008-2-CA-03 Epoxy-guaiane Derivatives and Treatment of Cancer CA National Stage 2711434 Issued
NCI E-064-2008-2-JP-05 Epoxy-guaiane Derivatives and Treatment of Cancer JP National Stage 2010-541518 Issued
NCI E-064-2008-2-AU-02 Epoxy-guaiane Derivatives And Treatment Of Cancer AU National Stage 2008347299 Issued
NIA E-243-2005-0-US-03 Susceptibility-Matched Multi-well Sample Holders For High-Throughput Screening by Magnetic Analysis US ORD 12/083,501 8427160 Abandoned PDF
NCI E-175-2002-0-US-03 METHOD OF TREATING ISCHEMIA/REPERFUSION INJURY WITH NITROXYL DONORS US CON 12/346,694 8268890 Expired PDF
NCI E-064-2008-2-LU-17 Epoxy-Guaiane Derivatives And Treatment of Cancer LU EP 08869946.7 Issued
NCI E-064-2008-2-NL-18 Epoxy-Guaiane Derivatives And Treatment of Cancer NL EP 08869946.7 Issued
NCI E-064-2008-2-DE-10 Epoxy-Guaiane Derivatives And Treatment of Cancer DE EP 08869946.7 Issued
NCI E-064-2008-2-FR-13 Epoxy-Guaiane Derivatives And Treatment of Cancer FR EP 08869946.7 Issued
NCI E-064-2008-2-BE-08 Epoxy-Guaiane Derivatives And Treatment of Cancer BE EP 08869946.7 Issued
NCI E-064-2008-2-AT-07 Epoxy-Guaiane Derivatives And Treatment of Cancer AT EP 08869946.7 Issued
NCI E-064-2008-2-DK-11 Epoxy-Guaiane Derivatives And Treatment of Cancer DK EP 08869946.7 Issued
NCI E-064-2008-2-IE-15 Epoxy-Guaiane Derivatives And Treatment of Cancer IE EP 08869946.7 Issued
NCI E-064-2008-2-IT-16 Epoxy-Guaiane Derivatives And Treatment of Cancer IT EP 08869946.7 Issued
NCI E-064-2008-2-EP-04 Epoxy-Guaiane Derivatives And Treatment of Cancer EP National Stage 08869946.7 Issued
NCI E-064-2008-2-GB-14 Epoxy-Guaiane Derivatives And Treatment of Cancer GB EP 08869946.7 Issued
NCI E-064-2008-2-CH-09 Epoxy-Guaiane Derivatives And Treatment of Cancer CH EP 08869946.7 Issued
NCI E-064-2008-2-SE-19 Epoxy-Guaiane Derivatives And Treatment of Cancer SE EP 08869946.7 Issued
NCI E-064-2008-2-NO-20 Epoxy-Guaiane Derivatives And Treatment of Cancer NO EP 08869946.7 Issued
NCI E-064-2008-2-ES-12 Epoxy-Guaiane Derivatives And Treatment of Cancer ES EP 08869946.7 Issued
NCI E-064-2008-2-PCT-01 Epoxy-guaiane Selective Renal Cancer Inhibitors PCT PCT COMB PCT/US2008/088529 Expired
NCI E-315-2007-0-PCT-02 Novel Natural Product Inhibitors Of ABCG2 PCT PCT PCT/US2008/088446 Expired
NCI E-325-2008-0-US-01 Survivin Specific T Cell Receptor For Immunotherapy Of Cancer US 61/140,338 Abandoned
NIEHS E-334-2008-0-US-01 Artificial Splicing Factors With PUF Protein RNA-binding Domain And Splicing Effector Domains US 61/140,326 Abandoned
NCI E-154-2009-0-US-01 INHIBITORS OF MRE11, RAD50 AND/OR NBS1 US 61/203,377 Abandoned